Human papillomavirus vaccines: organisation and experience of preclinical studies

INTRODUCTION. Vaccination is the main measure for the primary prevention of human papillomavirus (HPV)-related diseases. The development of novel vaccine candidates is underway worldwide, including in the Russian Federation. At the same time, the clinical introduction of new HPV vaccines is seriousl...

Popoln opis

Bibliografske podrobnosti

Principais autores:	A. S. Korovkin, T. N. Nikitina, T. Yu. Kozlova, D. V. Gorenkov, A. R. Volgin
Format:	Artigo
Jezik:	Russo
Izdano:	Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2024-10-01
Serija:	Биопрепараты: Профилактика, диагностика, лечение
Teme:	papillomavirus vaccines papillomavirus infections hpv vaccines vaccination capsid proteins l1 protein adjuvants hpv serotypes animals preclinical studies
Online dostop:	https://www.biopreparations.ru/jour/article/view/589
Oznake:	Označite Brez oznak, prvi označite!